FundingHealthcare & Life Sciences
Gabify raises $175,000 pre-seed led by IPV
By Abha Lohia · Editor ·
Gabify: funding and every story →
pre-seedFounded 2023
- Gabify provides an AI platform to screen and manage autism, ADHD, and other speech and neurological disorders
- It raised $175,000 in pre-seed funding led by Inflection Point Ventures, plus a ₹25 lakh grant from GHRTBI
- The platform uses dual-AI (voice and vision) and has been tested in 35+ preschools in India
What happened
- Gabify announced a $175,000 pre-seed funding round led by Inflection Point Ventures on 2 April 2026.
- It also received a ₹25 lakh grant under the Nidhi Seed Support Scheme from GHRTBI.
- The company was founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk.
- Gabify is described as India's first fully hosted SaaS ecosystem for speech and neurodevelopmental conditions.
- Its platform uses dual-AI (voice and vision) to analyse speech patterns, facial expressions, eye gaze, and behaviours.
- The system is aligned with 189+ clinically validated parameters from DSM-5 and CARS.
- It follows a human-in-the-loop model where AI outputs are reviewed by clinical experts.
- The platform has been tested in 35+ preschool and daycare centres in India during a private beta.
Why it matters
- Autism prevalence has risen to 1 in 30 children post-COVID, creating urgent need for scalable screening.
- India faces a shortage of therapists and long wait times, making AI-assisted tools critical.
- The global market for such solutions is estimated at USD 110 billion with a ~15% CAGR.
- Gabify's platform is designed for Bharat (rural India) with multilingual and low-bandwidth support.
The business
- Gabify offers an end-to-end AI screening and therapy management platform for autism, ADHD, and other speech and neurological disorders.
- Its dual-AI technology analyses both voice and vision inputs to detect signs of neurodevelopmental conditions.
- The platform uses 189+ clinically validated parameters based on DSM-5 and CARS standards.
- It follows a human-in-the-loop model where clinical experts review AI outputs before final diagnosis.
- The platform reduces assessment time by up to 70% compared to traditional methods.
- Gabify serves schools, hospitals, private practices, and NGOs as its primary users.
- It was tested in 35+ preschool and daycare centres in India during its private beta phase.
- The platform is designed for Bharat (rural India) with multilingual and low-bandwidth capabilities.
The founders
SC
Sahil Chopra
Founder & CEO- Has 12+ years of experience in the startup ecosystem.
- Founded Gabify in 2023.
PS
Prachi Sood
Co-founder & CMO- Senior speech therapist with 10+ years of clinical practice.
- Worked at Max and Fortis hospitals.
- Co-founded Gabify in 2023.
VL
Vasyl Leshchuk
Co-founder & CTO- Global CIO/CTO with 15+ years of experience in AI, cybersecurity, and IPO-scale technology.
- Previously worked at CIENCE and Freightos.
- Co-founded Gabify in 2023.
Who put in money
- Inflection Point Ventures lead — Angel investing platform that has invested over INR 1200 crore across 280+ startups.
In numbers
$175,000Pre-seed funding · 2026
₹25 lakhGrant from GHRTBI · 2026
up to 70%Assessment time reduction
35+Preschools tested in private beta
189+Clinically validated parameters
USD 110 billionGlobal market opportunity
1 in 30 childrenAutism prevalence post-COVID
What happens next
- Gabify will use the funds for clinical validation, technology enhancement, and team expansion.
- It aims to impact 1 million children by 2028 through B2B, B2C, and CSR-led rollouts.
Words to know
- Pre-seed
- The earliest stage of startup funding, typically used to develop a prototype or initial product.
- DSM-5
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition – the standard classification of mental disorders used by mental health professionals.
- CARS
- Childhood Autism Rating Scale – a tool used to diagnose autism in children.
- Human-in-the-loop (HITL)
- A model where AI outputs are reviewed and validated by human experts before final use.
The numbers around it
Gabify has 2 funding rounds in StopDown's archive, over ₹1 crore raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 15 May 2026 | Round | over ₹1 crore | IP Ventures |
Healthcare & Life Sciences in April 2026: 6 rounds with a disclosed amount, $15.0 million in all; the biggest was Coral ($12.5M). Every sector this year →
Other articles talking about it
Analytics Insight ↗expresshealthcare ↗CIOL ↗entrepreneur.economictimes.indiatimes ↗Indian Startup News ↗digitalhealthnews ↗cxodigitalpulse ↗indian-startup-times ↗Entrackr ↗Indian Startup Times ↗Inc42 ↗
Terms in this story
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
- Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on Gabify → · All startup news on 2 April 2026 →
Is this Gabify? Get your “Featured on StopDown” badge →